非专利(含维帕他韦方案)在埃及成人慢性HCV患者中对索非布韦加Daclatasvir方案治疗无反应的疗效和安全性

{"title":"非专利(含维帕他韦方案)在埃及成人慢性HCV患者中对索非布韦加Daclatasvir方案治疗无反应的疗效和安全性","authors":"Eman M. Fares, Wessam M. Ragab, Heba A. Eldash, Naglaa R. Ismael, Ahmed A. Gomaa","doi":"10.21608/djs.2023.302744","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11368,"journal":{"name":"Delta Journal of Science","volume":"74 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and Safety of Generic (Velpatasvir containing regimen) among Adult Chronic HCV Patients Non-responders to Treatment by Sofosbuvir Plus Daclatasvir Regimen in Egypt\",\"authors\":\"Eman M. Fares, Wessam M. Ragab, Heba A. Eldash, Naglaa R. Ismael, Ahmed A. Gomaa\",\"doi\":\"10.21608/djs.2023.302744\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11368,\"journal\":{\"name\":\"Delta Journal of Science\",\"volume\":\"74 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Delta Journal of Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/djs.2023.302744\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Delta Journal of Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/djs.2023.302744","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}